Adult Diagnostic (AD)
Instructional Level: Intermediate
Ototoxicity from platinum-based cancer chemotherapeutics and intravenous aminoglycoside antibiotics is a leading form of acquired hearing loss worldwide. Identifying early indicators of ototoxicity can prompt intervention to address the subsequent health and psychosocial consequences. Unfortunately, ototoxicity monitoring (OM) often fails to take place for patients receiving ototoxic therapies for essential, often life-preserving medical care. This talk will describe the underlying auditory injury, contrast leading OM methods to detect functional change; and demonstrate how to translate research results into clinical practice.